Clinical trial
Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
NCT00000174 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
- Lead sponsor
- Novartis
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.